KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $266.8 million.

  • Exact Sciences' Cost of Revenue rose 2113.19% to $266.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1825.19%. This contributed to the annual value of $894.1 million for FY2024, which is 801.15% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Cost of Revenue is $266.8 million, which was up 2113.19% from $248.6 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Cost of Revenue registered a high of $293.8 million during Q4 2022, and its lowest value of $119.1 million during Q4 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $215.9 million (2022), whereas its average is $217.3 million.
  • In the last 5 years, Exact Sciences' Cost of Revenue skyrocketed by 15012.45% in 2021 and then crashed by 2629.08% in 2023.
  • Over the past 5 years, Exact Sciences' Cost of Revenue (Quarter) stood at $119.1 million in 2021, then surged by 146.81% to $293.8 million in 2022, then dropped by 26.29% to $216.6 million in 2023, then rose by 12.9% to $244.5 million in 2024, then rose by 9.11% to $266.8 million in 2025.
  • Its Cost of Revenue was $266.8 million in Q3 2025, compared to $248.6 million in Q2 2025 and $264.3 million in Q1 2025.